A preferred reperfusion strategy for acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American College of Cardiology

• Publication date

  2003-12-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2003.09.010PMID 14662246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

  2003cited by this paper
• Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

  2003cited by this paper
• Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes: Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) Pilot Trial

  2003cited by this paper
• Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

  2003cited by this paper
• A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction.

  2002cited by this paper
• Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

  2002influential reference
• Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.

  2002cited by this paper
• GP IIb/IIIa inhibition in primary stenting: 'do it early, make it easy'.

  2002cited by this paper
• Effects of Abciximab on the Architecture of Platelet-Rich Clots in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001influential reference
• Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

  2000cited by this paper
• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.

  2000cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

  2000cited by this paper
• Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

  1999cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty- controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

  1998cited by this paper
• Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

  1998cited by this paper

• The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging

  2023cites this paper
• CLINICAL RESEARCH

  2021cites this paper
• Short title: Morphine impairs reperfusion pre-PPCI

  2019cites this paper
• Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size

  2018cites this paper
• Comparison of Angioplasty With Infusion ofTirofibanorAbciximabandWithImplantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction

  2017cites this paper
• IEWPOINT ationale and Strategies for Implementing ommunity-Based Transfer Protocols for rimary Percutaneous Coronary Intervention for cute ST-Segment Elevation Myocardial Infarction

  2016cites this paper
• The unexpected side effects and safety of therapeutic monoclonal antibodies.

  2014cites this paper
• Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register

  2014cites this paper
• The year in interventional cardiology.

  2013cites this paper
• Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention

  2013cites this paper
• Strategies to improve outcome in patients with ST elevation myocardial infarction treated with primary PCI

  2012cites this paper
• Primäre PCI versus Thrombolyse

  2012cites this paper
• Prótesis endovasculares medicadas contra de metal en la angioplastia primaria, reporte de un centro hospitalario en México

  2011cites this paper
• Antiplatelet therapy in myocardial infarction and coronary stent thrombosis

  2010cites this paper
• Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

  2010influential citation
• Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy

  2010cites this paper
• IIb or Not IIb: is there a place for pre-hospital tirofiban in ST-segment elevation myocardial infarction patients?

  2010cites this paper
• Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

  2010cites this paper
• Antithrombotic treatment in acute coronary syndromes.

  2010cites this paper
• Primary percutaneous coronary intervention decision‐making becomes more confusing: Where do glycoprotein 2b/3a inhibitors “fit” now?

  2009cites this paper
• Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction.

  2009cites this paper
• Platelet Glycoprotein IIb/IIIa Receptor Blockade in Primary Coronary Intervention

  2009cites this paper
• EARLY-ACS-Studie – GP-IIb/IIIa-Antagonisten: „Upstream“ oder „Downstream“?

  2009cites this paper
• Acute myocardial infarction associated with ST segment elevation and the new European Society of Cardiology guidelines

  2009cites this paper
• GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: New trial and registry data

  2008cites this paper
• Perkutane Koronarinterventionen (PCI)

  2008cites this paper
• Effect of intracoronary tirofiban in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

  2008cites this paper
• A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.

  2008cites this paper
• Determinants of final infarct size and incidence of aborted infarction in patients treated with primary coronary intervention and adjunctive abciximab therapy

  2008cites this paper
• Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.

  2008cites this paper
• Chapter 20 – Percutaneous coronary intervention for acute myocardial infarction

  2008cites this paper
• Effects of Coronary Prestenting Platelet Inhibition on Coronary Poststenting Inflammation

  2008cites this paper
• Drug Safety Evaluation

  2008cites this paper
• Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.

  2008cites this paper
• Percutaneous Coronary Intervention for Acute Myocardial Infarction

  2007cites this paper
• Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction

  2007cites this paper
• Genetics of Ischemic Heart Disease

  2007cites this paper
• Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.

  2007cites this paper
• Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction.

  2007cites this paper
• Use and efficacy of abciximab in an unselected population with acute myocardial infarction treated with primary angioplasty: data from AMI-Florence registry.

  2007cites this paper
• The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.

  2007cites this paper
• Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up.

  2007cites this paper
• Combined administration of barbourin--albumin and hirudin--albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta.

  2007cites this paper
• ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.

  2006cites this paper
• Akutes Koronarsyndrom

  2006cites this paper
• Current developments in anti-platelet therapy

  2006cites this paper
• CLINICAL RESEARCH Interventional Cardiology Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention Insights Into the STRATEGY Study

  2006cites this paper
• Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice

  2006cites this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cites this paper
• Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry

  2006cites this paper
• Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?

  2006cites this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cites this paper
• Cardiovascular emergencies in the elderly.

  2006cites this paper
• Newer Pharmacotherapy in Patients Undergoing Percutaneous Coronary Interventions: A Guide for Pharmacists and Other Health Care Professionals

  2006cites this paper
• Guidelines for the management of acute coronary syndromes 2006

  2006cites this paper
• "HEMORRAGIA INTRACRANEAL POST-TROMBOLISIS: DATOS DEL REGISTRO

  2006cites this paper
• updateof acute coronary syndromes: an

  2006cites this paper
• Koronare Herzkrankheit — akute Verlaufsformen

  2006cites this paper
• Guidelines for the management of acute coronary syndromes 2006

  2006cites this paper
• Antiplatelet Agents in Patients Undergoing Percutaneous Coronary Intervention

  2005cites this paper
• Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty

  2005influential citation
• Do we need the cardiologist in the prehospital triage for STEMI?

  2005cites this paper
• [Antithrombotic therapy during percutaneous coronary interventions].

  2005cites this paper
• Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

  2005cites this paper
• The year in interventional cardiology.

  2005cites this paper
• Myocardial infarction centres: the way forward

  2005cites this paper
• Platelets and new antiplatelet drugs

  2005cites this paper
• Patient selection bias in primary percutaneous coronary intervention trials: a critical issue

  2005cites this paper
• [Guidelines for percutaneous coronary interventions].

  2005cites this paper
• Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study.

  2005cites this paper
• Infarto agudo del miocardio con elevación del ST

  2005cites this paper
• The impact of adjunctive eptifibatide therapy with percutaneous coronary intervention for acute myocardial infarction

  2005cites this paper
• Guías de Práctica Clínica sobre intervencionismo coronario percutáneo

  2005cites this paper
• Angioplastia facilitada: ni blanco ni negro

  2005cites this paper
• New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios

  2005cites this paper
• Fibrinólise Imediata ou Transferência para Angioplastia Primária no Infarto Agudo do Miocárdio com Supradesnivelamento do Segmento ST? Quando e Como Transferir?

  2005cites this paper
• Primary percutaneous coronary intervention for acute MI: improving access and outcomes.

  2005cites this paper
• A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.

  2005cites this paper
• Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.

  2005cites this paper
• Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention.

  2005cites this paper
• Meta-analysis of Randomized Trials Acute ST-Segment Elevation Myocardial Infarction : A Abciximab as Adjunctive Therapy to Reperfusion in Correction

  2005cites this paper
• Management of Cardiogenic Shock Attributable to Acute Myocardial Infarction in the Reperfusion Era

  2005cites this paper
• Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

  2005cites this paper
• Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

  2005cites this paper
• [Facilitated angioplasty: neither black nor white].

  2005cites this paper
• Cardiac protection during acute myocardial infarction: where do we stand in 2004?

  2004cites this paper
• High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients

  2004cites this paper
• A L P A T I T I T H A A T Y E

  2004cites this paper
• Should patients with acute ST elevation MI be transferred for primary PCI?

  2004cites this paper
• Management of acute coronary syndromes: an update

  2004cites this paper
• Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.

  2004cites this paper
• Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials.

  2004cites this paper
• Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?

  2004cites this paper
• Intravenous Platelet Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes

  2004cites this paper
• Coronary disease MANAGEMENT OF ACUTE CORONARY SYNDROMES : AN UPDATE Keith A A Fox

  2004cites this paper
• The year in interventional cardiology.

  2004cites this paper
• Tirofiban for catheter intervention in acute myocardial infarction?

  2004cites this paper
• Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

  2004cites this paper
• Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.

  2004cites this paper
• Platelet-monocyte interaction and GPIIb/IIIa blockade

  2004cites this paper